The global pharmaceutical grade hyaluronic acid market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for hyaluronic acid in various applications such as eye drops, topical preparations, oral pharmaceutical preparations and intrarticular injection.
The global pharmaceutical grade sodium hyaluronate market is expected to grow at a CAGR of 4.8% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for sodium hyaluronate in various applications such as eye drops, topical preparations and oral pharmaceutical preparations.
Some Of The Growth Factors Of This Market:
- The increasing number of aging population is also expected to fuel growth in this market over the forecast period as it leads to an increase in demand for anti-aging products such as skin care creams and serums that contain high concentrations of hyaluronic acid.
- In addition, growing prevalence of chronic diseases such as arthritis and osteoarthritis is also expected to drive growth in this market over the forecast period due to increased use of pharmaceutical grade HA injections for pain relief and joint lubrication purposes among patients suffering from these conditions.
Industry Growth Insights published a new data on “Pharmaceutical Grade Hyaluronic Acid Market”. The research report is titled “Pharmaceutical Grade Hyaluronic Acid Market research by Types (Medical Grade Sodium Hyaluronate, Injection Grade Sodium Hyaluronate), By Applications (Eye Drops, Topical Preparations, Oral Pharmaceutical Preparations, Intra-articular Injection, Others), By Players/Companies Bloomage Bio Technology, LG Group, Nestlé, HUONS, Altergon Italia, Contipro, SYMATESE, RiverPharma, Freshine Chem”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Grade Hyaluronic Acid Market Research Report
By Type
Medical Grade Sodium Hyaluronate, Injection Grade Sodium Hyaluronate
By Application
Eye Drops, Topical Preparations, Oral Pharmaceutical Preparations, Intra-articular Injection, Others
By Companies
Bloomage Bio Technology, LG Group, Nestlé, HUONS, Altergon Italia, Contipro, SYMATESE, RiverPharma, Freshine Chem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Grade Hyaluronic Acid Market Report Segments:
The global Pharmaceutical Grade Hyaluronic Acid market is segmented on the basis of:
Types
Medical Grade Sodium Hyaluronate, Injection Grade Sodium Hyaluronate
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eye Drops, Topical Preparations, Oral Pharmaceutical Preparations, Intra-articular Injection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bloomage Bio Technology
- LG Group
- Nestlé
- HUONS
- Altergon Italia
- Contipro
- SYMATESE
- RiverPharma
- Freshine Chem
Highlights of The Pharmaceutical Grade Hyaluronic Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medical Grade Sodium Hyaluronate
- Injection Grade Sodium Hyaluronate
- By Application:
- Eye Drops
- Topical Preparations
- Oral Pharmaceutical Preparations
- Intra-articular Injection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Grade Hyaluronic Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical grade hyaluronic acid is a type of natural moisturizer that helps keep skin hydrated. It can be found in topical creams, gels, and injections.
Some of the major companies in the pharmaceutical grade hyaluronic acid market are Bloomage Bio Technology, LG Group, NestlƒÂ©, HUONS, Altergon Italia, Contipro, SYMATESE, RiverPharma, Freshine Chem.
The pharmaceutical grade hyaluronic acid market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Grade Hyaluronic Acid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Grade Hyaluronic Acid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Grade Hyaluronic Acid Market - Supply Chain
4.5. Global Pharmaceutical Grade Hyaluronic Acid Market Forecast
4.5.1. Pharmaceutical Grade Hyaluronic Acid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Grade Hyaluronic Acid Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Grade Hyaluronic Acid Market Absolute $ Opportunity
5. Global Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Type
5.3.1. Medical Grade Sodium Hyaluronate
5.3.2. Injection Grade Sodium Hyaluronate
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Application
6.3.1. Eye Drops
6.3.2. Topical Preparations
6.3.3. Oral Pharmaceutical Preparations
6.3.4. Intra-articular Injection
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Grade Hyaluronic Acid Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Application
9.4.1. Eye Drops
9.4.2. Topical Preparations
9.4.3. Oral Pharmaceutical Preparations
9.4.4. Intra-articular Injection
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Type
9.7.1. Medical Grade Sodium Hyaluronate
9.7.2. Injection Grade Sodium Hyaluronate
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Grade Hyaluronic Acid Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Application
10.4.1. Eye Drops
10.4.2. Topical Preparations
10.4.3. Oral Pharmaceutical Preparations
10.4.4. Intra-articular Injection
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Type
10.7.1. Medical Grade Sodium Hyaluronate
10.7.2. Injection Grade Sodium Hyaluronate
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Grade Hyaluronic Acid Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Application
11.4.1. Eye Drops
11.4.2. Topical Preparations
11.4.3. Oral Pharmaceutical Preparations
11.4.4. Intra-articular Injection
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Grae Hyaluronic Acid Market Size and Volume Forecast by Type
11.7.1. Medical Grade Sodium Hyaluronate
11.7.2. Injection Grade Sodium Hyaluronate
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Grade Hyaluronic Acid Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Application
12.4.1. Eye Drops
12.4.2. Topical Preparations
12.4.3. Oral Pharmaceutical Preparations
12.4.4. Intra-articular Injection
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Type
12.7.1. Medical Grade Sodium Hyaluronate
12.7.2. Injection Grade Sodium Hyaluronate
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Grade Hyaluronic Acid Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Grade Hyaluronic Acid Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Application
13.4.1. Eye Drops
13.4.2. Topical Preparations
13.4.3. Oral Pharmaceutical Preparations
13.4.4. Intra-articular Injection
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Grade Hyaluronic Acid Market Size and Volume Forecast by Type
13.7.1. Medical Grade Sodium Hyaluronate
13.7.2. Injection Grade Sodium Hyaluronate
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Grade Hyaluronic Acid Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Grade Hyaluronic Acid Market: Market Share Analysis
14.2. Pharmaceutical Grade Hyaluronic Acid Distributors and Customers
14.3. Pharmaceutical Grade Hyaluronic Acid Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bloomage Bio Technology
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. LG Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nestlé
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. HUONS
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Altergon Italia
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Contipro
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SYMATESE
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. RiverPharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Freshine Chem
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
